WP
FDMT icon

Woodline Partners’s 4D Molecular Therapeutics FDMT Stock Holding History

Woodline Partners’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.86M Hold
200,001
– – 0.01% 812
2025
Q4 		$1.5M Buy
+200,001
New +$2.03M 0.01% 808
2022
Q1 		– Sell
-132,117
Closed -$2.9M – 758
2021
Q4 		$2.9M Buy
132,117
+45,694
+53% +$1.12M 0.04% 370
2021
Q3 		$2.33M Buy
86,423
+47,715
+123% +$1.36M 0.04% 389
2021
Q2 		$932K Sell
38,708
-47,121
-55% -$1.44M 0.02% 444
2021
Q1 		$3.72M Sell
85,829
-17,624
-17% -$781K 0.08% 222
2020
Q4 		$4.29M Buy
+103,453
New +$4.27M 0.11% 163

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return